Search

Astellas Pharma Inc.
  • Top MenuTeam
  • Top MenuPortfolio
  • Top MenuContact
  • Top MenuNews

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  1. Home
  2. News

News

Important Notice

This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.

 

Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

Accept
Search
  • 2025
  • 2024
  • 2023
  • Previous
    • 2022
  • Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sep
  • Oct
  • Nov
  • Dec
Error

May 22, 2025

Global
May 22, 2025
Astellas and MBC BioLabs Announce the 2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio
Read More

Apr 09, 2025

Global
Apr 09, 2025
Solu Therapeutics Closes $41M Series A Financing and Announces First Patient Dosed in Phase 1 Clinical Trial of STX-0712 in Patients with CMML and Other Advanced Hematologic Malignancies
Read More

Feb 27, 2025

Global
Feb 27, 2025
Astellas and MBC BioLabs Announce the Sixth Annual Astellas Future Innovator Prize
Read More

Oct 29, 2024

Global
Oct 29, 2024
LabCentral and Astellas Announce Diamond Ticket Winner Quantum Sky
Read More

Sep 17, 2024

Global
Sep 17, 2024
Syntax Bio Launches with Strategic Backing from Astellas Venture Management LLC and Illumina Ventures
Read More

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page Next ›
  • Last page Last »

 

Contact

Astellas Venture Management LLC
480 Forbes Blvd, 
South San Francisco, CA 94080 
[email protected]

 

footer logofooter solgan

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • COOKIES POLICY
  • LEGAL DISCLAIMER
  • CONTACT
© Copyright 2024 Astellas Venture Management

Update cookie preferences